Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Wooridul Pharmaceutical Ltd

+ Add to Watchlist

004720:KS

7,400 KRW 150 1.99%

As of 02:29:36 ET on 05/22/2015.

Snapshot for Wooridul Pharmaceutical Ltd (004720)

Open: 7,650 Day's Range: 7,290 - 7,680 Volume: 178,107
Previous Close: 7,550 52wk Range: 2,580 - 9,490 1-Yr Rtn: +82.72%

Stock Chart for 004720

No chart data available.
  • 004720:KS 7,400
  • 1D
  • 1M
  • 1Y
7,550
Interactive 004720 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 004720

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) -579.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 60,290.45
Shares Outstanding (M) 8.15
30 Day Average Volume 1,228,984
Price/Book (mrq) 2.9712
Price/Sale (ttm) 1.3242
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 09/29/1994
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 004720

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 004720

Wooridul Pharmaceutical Ltd. develops, manufactures, and markets a variety of over the counter drugs. The Company's products include analgesics, antibiotics, anti-inflammatory drugs, cold relief tablets, and vitamins.

Ryu Nam-HyeonCEO/Rep DirectorKim Hye-YeonManaging Director
Han Eui-SangExecutive DirectorLee Keun-HyeongExecutive Director
More Company Profile & Key Executives for 004720

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil